Siegfried Holding AG
SFZN
Rang in aandelen
#4106
Siegfried Holding AG, together with its subsidiaries, engages in contract... Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. It offers drug substances, including exclusive synthesis that manufactures custom APIs. The company also offers an API portfolio, including non-exclusive APIs and pharma-grade substances that focus on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition. In addition, it offers drug products, including steriles, which includes fill and finish in vials, ampoules, cartridges, and pre-filled syringes; ophthalmics, such as sterile ointments, gels, and suspensions and solutions; inhalation products, including capsules in medical devices for inhalation applications; oral solid dosage forms, which includes tablets and capsules; and viral vectors, such as AAV and lentiviruses for gene therapy. Further, the company provides technologies with chemistry capabilities, analytical services, formulation technologies, bridging technologies, containment technology, and cell and gene therapies. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.
Aandeelprijs
$88.34
Marktkapitalisatie
$3.87B
Verandering (1 dag)
1.68%
Verandering (1 jaar)
-12.97%
Land
CH
Handel Siegfried Holding AG (SFZN)
Categorie
Healthcare
Aantal uitstaande aandelen voor Siegfried Holding AG (SFZN)
Aantal uitstaande aandelen per October 2026: 0
Volgens de laatste financiële rapporten en de aandelenkoers van Siegfried Holding AG bedraagt het huidige aantal uitstaande aandelen 0. Aan het einde van October 2026 had het bedrijf 0 uitstaande aandelen. Het aantal uitstaande aandelen wordt meestal beïnvloed door aandelensplitsingen en terugkoop van aandelen.
Geschiedenis van uitstaande aandelen van Siegfried Holding AG (SFZN) van 2002 tot 2026
Uitstaande aandelen aan het einde van elk jaar
| Jaar | Uitstaande aandelen | Wijzigen |
|---|---|---|
| 2025 | 43.76M | 1.54% |
| 2024 | 43.09M | 1.69% |
| 2023 | 42.38M | 0.40% |
| 2022 | 42.21M | 0.37% |
| 2021 | 42.05M | 1.45% |
| 2020 | 41.45M | 0.22% |
| 2019 | 41.36M | -0.67% |
| 2018 | 41.64M | 4.91% |
| 2017 | 39.69M | 2.15% |
| 2016 | 38.86M | -1.72% |
| 2015 | 39.54M | 2.20% |
| 2014 | 38.68M | -1.37% |
| 2013 | 39.22M | 8.27% |
| 2012 | 36.23M | -1.32% |
| 2011 | 36.71M | 8.64% |
| 2010 | 33.79M | 22.52% |
| 2009 | 27.58M | -0.49% |
| 2008 | 27.71M | 0.30% |
| 2007 | 27.63M | -0.21% |
| 2006 | 27.69M | 0.25% |
| 2005 | 27.62M | 1.23% |
| 2004 | 27.28M | 0.00% |
| 2003 | 27.28M | -0.13% |
| 2002 | 27.32M | 0.00% |
Uitstaande aandelen van vergelijkbare bedrijven of concurrenten
| Bedrijf | Uitstaande aandelen | Verschil | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | - |
IN
|
